Edinburgh Postnatal Depression Scale (EPDS)
The EPDS is a 10-question screening tool that assesses symptoms over the past 7 days, scored from 0-30, with a cutoff of ≥10 indicating possible depression requiring further evaluation. 1
What the EPDS Is
The EPDS is the most robustly validated and recommended screening instrument for postpartum depression, specifically developed for use in postpartum women 1. It received the only Class A recommendation among 10 evaluated screening tools based on adequate content validity, moderate evidence for internal consistency, and sufficient structural validity 1. The scale has been translated into over 60 languages and demonstrates superior psychometric properties compared to general depression screening tools 1.
Scoring System
- Number of questions: 10 items
- Score range: 0-30 (lower scores indicate less depression)
- Time period assessed: Past 7 days
- Completion time: Approximately 5 minutes 2
- Scoring method: Each question uses different response options scored 0-3 points 1
Cutoff Scores and Interpretation
The evidence shows varying cutoff recommendations depending on the clinical context:
Standard screening cutoffs:
- ≥10 points: Possible depression - indicates need for further evaluation 1
- ≥11 points: Maximizes combined sensitivity and specificity across multiple studies 1
- ≥13 points: Probable depression - suggests immediate further assessment is necessary 3
Important nuance: A detailed analysis of 58 validation studies found that a cutoff of 11 or higher optimizes the balance between sensitivity and specificity 1. However, sensitivity ranges from 34-100% and specificity from 44-100% across different studies, reflecting heterogeneity in methodology, language, and diagnostic criteria used 4.
When to Administer
Multiple timepoints are supported by evidence:
At 2-3 days postpartum (delivery discharge):
At postpartum day 3:
At 4-6 weeks postpartum:
- Traditional screening timepoint
- Remains important as 8.2% of women with low scores at discharge will convert to positive 5
Clinical Algorithm for Implementation
Screen at delivery discharge (day 2-3):
- Score ≥9 → High risk, arrange close follow-up and consider early intervention
- Score 5-8 → Moderate risk, provide supportive resources and rescreen at postpartum visit
- Score <5 → Low risk, routine rescreening at postpartum visit
Rescreen at 2-6 weeks postpartum (universal):
- Captures the 8.2% who convert from low to high risk 5
- Score ≥10 → Further evaluation required
- Score ≥13 → Immediate assessment and treatment planning
Key Clinical Caveats
Risk factors requiring heightened surveillance:
- Personal history of depression (significantly associated with PPD) 7
- Marital instability 3
- Lack of medical insurance 3
- EPDS ≥9 at delivery discharge 7
Critical safety consideration: Always assess question 10 regarding self-harm thoughts, regardless of total score. In one study, 2.3% endorsed self-harm at delivery discharge 5.
Limitations to recognize:
- The EPDS is a screening tool, not a diagnostic instrument 1
- Gold standard diagnosis requires SCID-5 or psychiatric consultation 1
- Does not include questions about infant-related concerns 1
- Cross-cultural validity has not been adequately evaluated despite widespread translation 1
Practical advantages:
- Freely available (no purchase required) 1
- Brief administration time
- Sensitive to changes in depression severity over time 2
- Can be completed by patients independently
The EPDS should be used by all clinicians caring for perinatal women, with screening at both delivery discharge and the postpartum visit to maximize detection while minimizing false negatives 1, 5.